Skip to main content

RESMED INC

For the period ended Dec 31, 2023. Filed Jan 25, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Dec 31, 2023 · Filed Jan 25, 2024

RMD$234.11-0.7%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Changes in Equity (Unaudited)

PART I – FINANCIAL INFORMATIONItem 1

Condensed Consolidated Statements of Changes in Equity (Unaudited)

Common Stock · AdditionalPaid-in Capital · Treasury Stock · RetainedEarnings · AccumulatedOtherComprehensive Income (Loss) · Total
Shares · Amount · Shares · Amount
Balance, June 30, 2023188,901$588$1,772,083(41,836)$(1,623,256)$4,253,016$(272,528)$4,129,903
Common stock issued on exercise of options17—983————983
Common stock issued on vesting of restricted stock units, net of shares withheld for tax3—(225)————(225)
Stock-based compensation costs——18,510————18,510
Other comprehensive loss——————(47,620)(47,620)
Net income—————219,422—219,422
Dividends declared ($0.48 per common share)—————(70,597)—(70,597)
Balance, September 30, 2023188,921$588$1,791,351(41,836)$(1,623,256)$4,401,841$(320,148)$4,250,376
Common stock issued on exercise of options24—1,557————1,557
Common stock issued on vesting of restricted stock units, net of shares withheld for tax1631(7,798)————(7,797)
Common stock issued on employee stock purchase plan151117,966————17,967
Treasury stock purchases—(2)2(336)(50,007)——(50,007)
Stock-based compensation costs——19,840————19,840
Other comprehensive income——————111,796111,796
Net income—————208,800—208,800
Dividends declared ($0.48 per common share)—————(70,678)—(70,678)
Balance, December 31, 2023189,259$588$1,822,918(42,172)$(1,673,263)$4,539,963$(208,352)$4,481,854
PART I – FINANCIAL INFORMATIONItem 1

Condensed Consolidated Statements of Changes in Equity (Unaudited)

Common Stock · AdditionalPaid-inCapital · Treasury Stock · RetainedEarnings · AccumulatedOtherComprehensive Income (Loss) · Total
Shares · Amount · Shares · Amount
Balance, June 30, 2022188,247$586$1,682,432(41,836)$(1,623,256)$3,613,736$(312,747)$3,360,751
Common stock issued on exercise of options45—2,610————2,610
Common stock issued on vesting of restricted stock units, net of shares withheld for tax3—(59)————(59)
Stock-based compensation costs——16,919————16,919
Other comprehensive loss——————(93,381)(93,381)
Net income—————210,478—210,478
Dividends declared ($0.44 per common share)—————(64,431)—(64,431)
Balance, September 30, 2022188,295$586$1,701,902(41,836)$(1,623,256)$3,759,783$(406,128)$3,432,887
Common stock issued on exercise of options77—5,120————5,120
Common stock issued on vesting of restricted stock units, net of shares withheld for tax2651(29,655)————(29,654)
Common stock issued on employee stock purchase plan100116,935————16,936
Stock-based compensation costs——16,464————16,464
Other comprehensive income (loss)——————135,960135,960
Net income—————224,914—224,914
Dividends declared ($0.44 per common share)—————(64,500)—(64,500)
Balance, December 31, 2022188,737$588$1,710,766(41,836)$(1,623,256)$3,920,197$(270,168)$3,738,127
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.